Aclaris Therapeutics Inc (ACRS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ACRS Giù? Forum Previsione

Aclaris Therapeutics Inc Azioni (ACRS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	22.13% 1.777	1.455	9.211	4.346	-
Cost Of Revenue	1.78% 0.515	0.506	0.705	0.654	-
Gross Profit	32.98% 1.262	0.949	8.506	3.692	-
Operating Expenses	3.35% 19.67	19.03	108.18	14.16	-
Benefits Costs and Expenses	4.03% 17.21	16.54	105.76	14.82	-
Costs And Expenses	3.31% 20.18	19.54	108.89	14.82	-
Operating Income/Loss	1.79% -18.41	-18.08	-99.67	-10.47	-
Nonoperating Income/Loss	0.67% 2.979	2.999	3.123	2.885	-
Income/Loss From Continuing Operations Before Tax	2.28% -15.43	-15.09	-96.55	-10.47	-10.99
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	2.28% -15.43	-15.09	-96.55	-7.586	-10.99
Net Income/Loss	2.28% -15.43	-15.09	-96.55	-7.586	-10.99
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.16% 122.58	122.39	6.0469	71.38	-
Diluted Average Shares	0.16% 122.58	122.39	6.0469	71.38	-
Basic Earnings Per Share	8.33% -0.13	-0.12	-1.21	-0.11	-
Diluted Earnings Per Share	8.33% -0.13	-0.12	-1.21	-0.11	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%